• Home
  • Contact

Tag: Oncolytic Virus

News

Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology

3 weeks ago 4 Likes 30
News

Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms

3 months ago 4 Likes 44
News

Enemy or Valuable Ally? How Biotech Uses Viruses for Good

4 months ago 7 Likes 65
News

Gene Therapy: Can CROs Solve the Manufacturing Bottleneck?

12 months ago 3 Likes 110
News

This Startup is Making a Cancer Vaccine out of Viruses

1 year ago 5 Likes 88

Recent Posts

  • Achilles Therapeutics’ IPO Caps Investment Wave for Neoantigens
  • DBV Battles Aimmune for Share of Peanut Allergy Treatment Market
  • Biomaterials Are Making the Building Industry More Sustainable
  • Eight Diseases CRISPR Technology Could Cure
  • On Our Way to Covid-19 Immunity
  • How Augmented Reality Strengthens Biotech Manufacturing
  • Appreciating van Leeuwenhoek: The Cloth Merchant Who Discovered Microbes
  • Data Management: Taking the Right Turn at the Clinical Trial Crossroads
  • Base Editing: The Next Frontier in Genome Editing Technology 
  • Have European Investors Missed the Exosome ‘Gold Rush’?
© 2020 biotechTODAY - Designed by Legendary Group